# US 2015/0031670 A1 · Cyclic amides as metap-2 inhibitors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0031670 A1
- Document ID: US20150031670A1
- Status: Published application
- Kind: A1
- Application number: 14/390,926
- Filed: 2013-03-21
- Published: 2015-01-29
- Earliest claimed: 2012-04-04
- Assignees: Merck Patent GmbH
- Applicants: MERCK PATENT GmbH
- Inventors: Timo Heinrich; Frank Zenke; Mireille Krier; Manja Friese-Hamim; Jeyaprakashnarayanan Seenisamy
- Web page: https://patentgrep.com/patent/US20150031670A1

## CPC

- C07D 207/277: Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- A61K 31/40: having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K 31/402: 1-aryl substituted, e.g. piretanide
- A61K 31/4035: Isoindoles, e.g. phthalimide
- A61K 31/4184: condensed with carbocyclic rings, e.g. benzimidazoles
- A61K 31/445: Non condensed piperidines, e.g. piperocaine
- A61K 31/45: having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
- A61K 31/451: having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
- A61K 31/541: Non-condensed thiazines containing further heterocyclic rings
- A61K 31/55: having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 1/02: Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A61P 3/04: Anorexiants; Antiobesity agents
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 11/00: Drugs for disorders of the respiratory system
- A61P 11/06: Antiasthmatics
- A61P 13/08: of the prostate
- A61P 13/12: of the kidneys
- A61P 17/06: Antipsoriatics
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 19/10: for osteoporosis
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 27/02: Ophthalmic agents
- A61P 27/06: Antiglaucoma agents or miotics
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 33/06: Antimalarials
- A61P 35/00: Antineoplastic agents
- A61P 35/02: specific for leukemia
- A61P 35/04: specific for metastasis
- A61P 37/06: Immunosuppressants, e.g. drugs for graft rejection
- A61P 37/08: Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14)
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 207/12: Oxygen or sulfur atoms
- C07D 207/16: Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D 207/24: Oxygen or sulfur atoms
- C07D 207/26: 2-Pyrrolidones
- C07D 207/267: with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to the ring nitrogen atom
- C07D 211/60: Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D 211/74: Oxygen atoms
- C07D 211/76: attached in position 2 or 6
- C07D 211/78: Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D 223/08: Oxygen atoms
- C07D 223/10: attached in position 2
- C07D 401/04: directly linked by a ring-member-to-ring-member bond
- C07D 401/06: linked by a carbon chain containing only aliphatic carbon atoms
- C07D 401/10: linked by a carbon chain containing aromatic rings
- C07D 403/04: directly linked by a ring-member-to-ring-member bond
- C07D 403/06: linked by a carbon chain containing only aliphatic carbon atoms
- C07D 403/10: linked by a carbon chain containing aromatic rings
- C07D 403/14: containing three or more hetero rings
- C07D 417/06: linked by a carbon chain containing only aliphatic carbon atoms
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

Compounds of the formula (I), in which R1, R3, R5, R6, R7, R, X and Y have the meanings indicated in Claim 1, are inhibitors of methionine aminopeptidase and can be employed for the treatment of tumours.

## Claims

### Claim 1

Compounds of the formula I
in which
R denotes NR2R4, Alk, C(═CH2)[C(R4)2]nAr2, Het2, O[C(R4)2]nAr2 or OA,
X denotes CO or CH2,
Y denotes CO or CH2,
R1 denotes H, [C(R4)2]nAr1, (CH2)nHet, (CH2)nCyc, [C(R4)2]nCOOH, [C(R4)2]nCONHAr1, [C(R4)2]nCONH2, [C(R4)2]nNHA, [C(R4)2]nNA2, O[C(R4)2]nAr1, [C(R4)2]nOR7, [C(R4)2]nCOO(CH2)nAr1, [C(R4)2]nCOOA, [C(R4)2]CONH[C(R4)2]pCON(R4)2 or [C(R4)2]CONHCR4—[(CH2)nN(R4)2]CON(R4)2,
R2 denotes H, [C(R4)2]nAr2, (CH2)nCOHet1, (CH2)nCOAr2, (CH2)mNA2 or (CH2)nHet,
R3 denotes OH or OCOA,
R4 denotes H or alkyl having 1, 2, 3 or 4 C atoms,
R2 and R4 together also denote alkylene having 2, 3, 4 or 5 C atoms, where a CH2 group may also be replaced by N(CH2)mOH or SO2,
R5, R6 each, independently of one another, denote H, F or A,
R5 and R6 together also denote alkylene having 2, 3, 4 or 5 C atoms, where a CH2 group may also be replaced by NCOA or O,
R7 denotes H or A,
Ar1 denotes phenyl which is unsubstituted or mono-, di-, tri-, tetra- or pentasubstituted by Hal, OH, OA, CONH2, CONHA, CONA2, NHSO2A, CONHCyc, NHSO2Cyc, CONHAr2, COHet1 and/or NASO2A,
Ar2 denotes phenyl which is unsubstituted or mono-, di-, tri-, tetra- or pentasubstituted by Hal, A, CONH2, and/or OAr3,
Ar3 denotes phenyl which is unsubstituted or monosubstituted by NH2,
Het denotes a mono- or bicyclic saturated, unsaturated or aromatic heterocycle having 1 to 4 N, and/or O and/or S atoms which is unsubstituted or mono-, di- or trisubstituted by Hal, A, OA, CN, NH2, NHA, NA2, NO2, CN, COOH, COOA, (CH2)nCONH2, (CH2)nCONHA, (CH2)nCONA2, NHCOA, COA, CHO, Het1, SO2A, SO2NH2, SO2NHA, SO2NA2, CONHNH2, CONHAr3, ═O and/or Ar3,
Het1 denotes a monocyclic saturated heterocycle having 1 to 4 N, and/or O and/or S atoms which is unsubstituted or mono-, di- or trisubstituted by ═O and/or COOA,
Het2 denotes isoindolyl,
A denotes unbranched or branched alkyl having 1-10 C atoms, in which 1-7 H atoms may be replaced by F, Cl, Br, OH, CHO, COA, COOA, CN, CONA2, CONHA and/or CONH2,
and/or in which one or two non-adjacent CH and/or CH2 groups may be replaced by O,
or Cyc,
Alk denotes alkenyl having 2, 3, 4, 5 or 6 C atoms
Cyc denotes cyclic alkyl having 3-7 C atoms which is unsubstituted or 3 MERCK-4238 mono-, di- or trisubstituted by NHCOA, NHSO2, OH, OA, A, NH2, NHA, NA2, COOA, COOH and/or CONHA,
Hal denotes F, Cl, Br or I,
m denotes 1, 2, 3 or 4,
n denotes 0, 1, 2, 3 or 4,
p denotes 1, 2 or 3,
and pharmaceutically usable salts, tautomers and stereoisomers thereof, including mixtures thereof in all ratios.

### Claim 2 (depends on 1)

Compounds according to claim 1 in which
Het denotes pyrazinyl, pyrazolyl, benzimidazolyl, pyridyl, indolyl, dihydroindolyl, benzofuranyl, tetrahydropyranyl, dihydroquinolinyl, dihydroisoquinolinyl, tetrahydroquinolinyl, tetrahydroisoquinolinyl, indazolyl, imidazolyl, pyrrolyl, oxazolyl, oxadiazolyl, isoxazolyl, benzothiazolyl, piperidin-1-yl, pyrrolidin-1-yl, 3,4-dihydro-2H-pyrido[3,2-b]-1,4-oxazinyl, 3,4-dihydro-2H-benzo-1,4-oxazinyl, benzofuranyl, azetidinyl, 3-azabicylo[3.2.0]hexyl, pyrrolo[2,3-b]pyridinyl, tetrahydrofuranyl, tetrahydro-1,8-naphthyridinyl, 2,3-dihydrobenzoisothiazolyl, 1,2,3,4-tetrahydrobenzothiazinyl or hexahydrobenzo-1,3-dioxolyl, each of which is unsubstituted or mono-, di- or trisubstituted by Hal, A, OA, CN, NH2, NHA, NA2, NO2, CN, COOH, COOA, (CH2)nCONH2, (CH2)nCONHA, (CH2)nCONA2, NHCOA, COA, CHO, Het1, SO2A, SO2NH2, SO2NHA, SO2NA2, CONHNH2, CONHAr3, ═O and/or Ar3,
and pharmaceutically usable salts, tautomers and stereoisomers thereof, including mixtures thereof in all ratios.

### Claim 3 (depends on 1)

Compounds according to claim 1 in which
Het1 denotes pyridazinyl, pyrazolyl, pyridyl, piperazinyl, morpholinyl, pyrimidinyl, furyl, thienyl, imidazolyl, pyrrolyl, oxazolyl, oxadiazolyl, isoxazolyl, thiazolyl, triazolyl, tetrazolyl, thiadiazole, piperidin-1-yl, pyrrolidin-1-yl, tetrahydropyranyl, 1,2-oxazinan-2-yl, 1,2,5-oxadiazinan-2-yl, 1,3-oxazinan-3-yl or hexahydropyrimidinyl, each of which is unsubstituted or mono-, di- or trisubstituted by A and/or OA,
and pharmaceutically usable salts, tautomers and stereoisomers thereof, including mixtures thereof in all ratios.

### Claim 4 (depends on 1)

Compounds according to claim 1 in which
R denotes NR2R4, Alk, C(═CH2)[C(R4)2]nAr2, Het2, O[C(R4)2]nAr2 or OA,
X denotes CO or CH2,
Y denotes CO or CH2,
R1 denotes H, [C(R4)2]nAr1, (CH2)nHet, (CH2)nCyc, [C(R4)2]nCOOH, [C(R4)2]nCONHAr1, [C(R4)2]nCONH2, [C(R4)2]nNHA, [C(R4)2]nNA2, O[C(R4)2]nAr1, [C(R4)2]nOR7, [C(R4)2]nCOO—(CH2)nAr1, [C(R4)2]nCOOA, [C(R4)2]nCONH[C(R4)2]pCON(R4)2 or [C(R4)2]nCONHCR4[(CH2)nN(R4)2]CON(R4)2,
R2 denotes H, [C(R4)2]nAr2, (CH2)nCOHet1, (CH2)nCOAr2, (CH2)mNA2 or (CH2)nHet,
R3 denotes OH or OCOA,
R4 denotes H or alkyl having 1, 2, 3 or 4 C atoms,
R2 and R4 together also denote alkylene having 2, 3, 4 or 5 C atoms, where a CH2 group may also be replaced by N(CH2)mOH or SO2,
R5, R6 each, independently of one another, denote H, F or A,
R5 and R6 together also denote alkylene having 2, 3, 4 or 5 C atoms, where a CH2 group may also be replaced by NCOA or O,
R7 denotes H or A,
Ar1 denotes phenyl which is unsubstituted or mono-, di-, tri-, tetra- or pentasubstituted by Hal, OH, OA, CONH2, CONHA, CONA2, NHSO2A, CONHCyc, NHSO2Cyc, CONHAr2, COHet1 and/or NASO2A,
Ar2 denotes phenyl which is unsubstituted or mono-, di-, tri-, tetra- or pentasubstituted by Hal, A, CONH2, and/or OAr3,
Ar3 denotes phenyl which is unsubstituted or monosubstituted by NH2,
Het denotes pyrazinyl, pyrazolyl, benzimidazolyl, pyridyl, indolyl, dihydroindolyl, benzofuranyl, tetrahydropyranyl, dihydroquinolinyl, dihydroisoquinolinyl, tetrahydroquinolinyl, tetrahydroisoquinolinyl, indazolyl, imidazolyl, pyrrolyl, oxazolyl, oxadiazolyl, isoxazolyl, benzothiazolyl, piperidin-1-yl, pyrrolidin-1-yl, 3,4-dihydro-2H-pyrido[3,2-b]-1,4-oxazinyl, 3,4-dihydro-2H-benzo-1,4-oxazinyl, benzofuranyl, azetidinyl, 3-azabicylo[3.2.0]hexyl, pyrrolo[2,3-b]pyridinyl, tetrahydrofuranyl, tetrahydro-1,8-naphthyridinyl 2,3-dihydrobenzoisothiazolyl, 1,2,3,4-tetrahydrobenzothiazinyl or hexahydrobenzo-1,3-dioxolyl, each of which is unsubstituted or mono-, di- or trisubstituted by Hal, A, OA, CN, NH2, NHA, NA2, NO2, CN, COOH, COOA, (CH2)nCONH2, (CH2)nCONHA, (CH2)nCONA2, NHCOA, COA, CHO, Het1, SO2A, SO2NH2, SO2NHA, SO2NA2, CONHNH2, CONHAr3, ═O and/or Ar3,
Het1 denotes pyridazinyl, pyrazolyl, pyridyl, piperazinyl, morpholinyl, pyrimidinyl, furyl, thienyl, imidazolyl, pyrrolyl, oxazolyl, oxadiazolyl, isoxazolyl, thiazolyl, triazolyl, tetrazolyl, thiadiazole, piperidin-1-yl, pyrrolidin-1-yl, tetrahydropyranyl, 1,2-oxazinan-2-yl, 1,2,5-oxadiazinan-2-yl, 1,3-oxazinan-3-yl or hexahydropyrimidinyl, each of which is unsubstituted or mono-, di- or trisubstituted by A and/or OA,
Het2 denotes isoindolyl,
A denotes unbranched or branched alkyl having 1-10 C atoms, in which 1-7 H atoms may be replaced by F, Cl, Br, OH, CHO, COA, COOA, CN, CONA2, CONHA and/or CONH2,
and/or in which one or two non-adjacent CH and/or CH2 groups may be replaced by O,
or Cyc,
Alk denotes alkenyl having 2, 3, 4, 5 or 6 C atoms
Cyc denotes cyclic alkyl having 3-7 C atoms which is unsubstituted or mono-, di- or trisubstituted by NHCOA, NHSO2, OH, OA, A, NH2, NHA, NA2, COOA, COOH and/or CONHA,
Hal denotes F, Cl, Br or I,
m denotes 1, 2, 3 or 4,
n denotes 0, 1, 2, 3 or 4,
p denotes 1, 2 or 3,
and pharmaceutically usable salts, tautomers and stereoisomers thereof, including mixtures thereof in all ratios.

### Claim 5 (depends on 1)

Compounds according to claim 1, selected from the group
Compound
No.
Name
“A56”
(S)-3-(1,1-Dioxo-1l6-thiomorpholine-4-carbonyl)-3-
hydroxy-1-phenylpyrrolidin-2-one
“A57”
(S)-3-Hydroxy-3-[4-(2-hydroxyethyl)piperazine-1-
carbonyl]-1-phenylpyrrolidin-2-one
“A58”
N-(3-Imidazol-1-ylpropyl)-(S)-3-hydroxy-2-oxo-1-
phenyl-pyrrolidine-3-carboxamide
“A59”
N-(2-Dimethylaminoethyl)-(S)-3-hydroxy-2-oxo-1-
phenyl-pyrrolidine-3-carboxamide
“A60”
N-[2-(4-Phenoxyphenyl)ethyl]-(S)-3-hydroxy-2-
oxo-1-phenyl-pyrrolidine-3-carboxamide
“A61”
N-(2-Dimethylaminoethyl)methyl)-(S)-3-hydroxy-2-
oxo-1-phenyl-pyrrolidine-3-carboxamide
“A62”
N-(2-Morpholin-4-yl-2-oxoethyl)-(S)-3-hydroxy-2-
oxo-1-phenyl-pyrrolidine-3-carboxamide
“A63”
N-[2-(1-Methylpyrrolidin-2-yl)ethyl]-(S)-3-hydroxy-
2-oxo-1-phenylpyrrolidine-3-carboxamide
“A64”
N-(3-Dimethylaminopropyl)-(S)-3-hydroxy-2-
oxo-1-phenyl-pyrrolidine-3-carboxamide
“A65”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-2-oxo-1-
phenylpiperidine-3-carboxamide
“A66”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-2-
oxo-1-phenylazepane-3-carboxamide
“A67”
N-(3-Chloro-5-fluorobenzyl)-(R)-3-hydroxy-2-
oxo-1-phenylazepane-3-carboxamide
“A68”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-1-(1H-
indol-6-yl)-2-oxo-pyrrolidine-3-carboxamide
“A69”
N-(3-Chloro-5-fluorobenzyl)-1-[3-(3-
carbamoylphenylcarbamoyl)-phenyl]-3-hydroxy-
2-oxopyrrolidine-3-carboxamide
“A70”
(S)-3-((E)-But-2-enoyl)-3-hydroxy-1-
phenylpyrrolidin-2-one
“A71”
N-(3-Chloro-5-fluorobenzyl)-(S)-8-acetyl-4-hydroxy-3-
oxo-2-phenyl-2,8-diazaspiro[4.5]decane-4-carboxamide
“A72”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-1-
[3-(morpholine-4-carbonyl)phenyl]-2-oxopyrrolidine-
3-carboxamide
“A73”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-1-
[3-(methanesulfonyl-methylamino)phenyl]-2-
oxopyrrolidine-3-carboxamide
“A74”
N-(3-Chloro-5-fluorobenzyl)-(R)-3-hydroxy-1-
[3-(morpholine-4-carbonyl)phenyl]-2-
oxopyrrolidine-3-carboxamide
“A75”
N-(3-Chloro-5-fluorobenzyl)-(S)-1-(3-
cyclopropylcarbamoylphenyl)-3-hydroxy-2-
oxopyrrolidine-3-carboxamide
“A76”
N-(3-Chloro-5-fluorobenzyl)-1-
(3-cyclobutylcarbamoylphenyl)-3-
hydroxy-2-oxopyrrolidine-3-carboxamide
“A77”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-2-oxo-1-
[3-(pyrrolidine-1-carbonyl)phenyl]
pyrrolidine-3-carboxamide
“A78”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-2-oxo-1-
(6-propionylaminopyridin-3-yl)pyrrolidine-3
-carboxamide
“A79”
N-(3-Chloro-5-fluorobenzyl)-(S)-1-
(3-ethanesulfonylaminophenyl)-3-hydroxy-2-
oxopyrrolidine-3-carboxamide
“A80”
N-(3-Chloro-5-fluorobenzyl)-(S)-1-
(3-cyclopropanesulfonylamino-phenyl)-3-hydroxy-2-
oxopyrrolidine-3-carboxamide
“A81”
N-(3-Chloro-5-fluorobenzyl)-(S)-1-benzyl-3-hydroxy-
2-oxo-piperidine-3-carboxamide
“A82”
N-(3-Chloro-5-fluorobenzyl)-(R)-1-
(3-cyclopropylcarbamoyl-phenyl)-3-hydroxy-
2-oxopyrrolidine-3-carboxamide
“A83”
N-(3-Chloro-5-fluorobenzyl)-(R)-3-hydroxy-2-oxo-1-[3-
(pyrrolidine-1-carbonyl)phenyl]pyrrolidine-3-carboxamide
“A84”
N-(3-Chloro-5-fluorobenzyl)-(R)-1-(3-ethanesulfonylamino-
phenyl)-3-hydroxy-2-oxopyrrolidine-3-carboxamide
“A85”
N-(3-Chloro-5-fluorobenzyl)-(R)-1-(3-
cyclopropanesulfonylamino-phenyl)-3-
hydroxy-2-oxopyrrolidine-3-carboxamidee
“A86”
N-(3-Chloro-5-fluorobenzyl)-(R)-1-benzyl-3-hydroxy-
2-oxo-piperidine-3-carboxamide
“A87”
N-(3-Chloro-5-fluorobenzyl)-1-(3-cyano-1H-indol-
5-yl)-3-hydroxy-2-oxopyrrolidine-3-carboxamide
“A88”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-1-
[3-(2-hydroxy-ethylcarbamoyl)phenyl]-
2-oxopyrrolidine-3-carboxamide
“A89”
3-(2-Benzylacryloyl)-3-hydroxy-1-
phenylpyrrolidin-2-on
“A90”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-2-oxo-
1-phenethyl-pyrrolidine-3-carboxamide
“A91”
N-(3-Chloro-5-fluorobenzyl)-(R)-3-hydroxy-1-
[3-(2-hydroxy-ethylcarbamoyl)phenyl]-
2-oxopyrrolidine-3-carboxamide
“A92”
N-(3-Chloro-5-fluorobenzyl)-(R)-3-hydroxy-2-
oxo-1-phenethyl-pyrrolidine-3-carboxamide
“A93”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-1-
{3-[(2-hydroxy-ethyl)methylcarbamoyl]phenyl}-
2-oxopyrrolidine-3-carboxamide
“A94”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-1-
[3-(3-hydroxy-propylcarbamoyl)phenyl]-
2-oxopyrrolidine-3-carboxamide
“A95”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-2-oxo-1-[3-
(piperidin-1-carbonyl)phenyl]pyrrolidine-3-carboxamide
“A96”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-2-oxo-1-(1-oxo-
1,2,3,4-tetrahydroisoquinolin-6-yl)pyrrolidine-3-carboxamide
“A97”
N-(3-Chloro-5-fluorobenzyl)-(S)-1-(6-cyanopyridin-3-yl)-
3-hydroxy-2-oxopyrrolidine-3-carboxamide
“A98”
N-(3-Chloro-5-fluorobenzyl)-(R)-1-(5-cyanopyridin-3-yl)-
3-hydroxy-2-oxopyrrolidine-3-carboxamide
“A99”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-2-oxo-1-(6-
trifluoromethylpyridin-3-yl)pyrrolidine-3-carboxamide
“A100”
Methyl 5-[3-(3-chloro-5-fluorobenzylcarbamoyl)-3-
hydroxy-2-oxopyrrolidin-1-yl]-2-methylnicotinate
“A101”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-4,4-
dimethyl-2-oxo-1-phenylpyrrolidine-3-carboxamide
“A102”
N-(3-Chloro-5-fluorobenzyl)-(R)-3-hydroxy-1-
{3-[(2-hydroxy-ethyl)methylcarbamoyl]phenyl}-
2-oxopyrrolidine-3-carboxamide
“A103”
N-(3-Chloro-5-fluorobenzyl)-(R)-3-hydroxy-1-
propylcarbamoyl)phenyl]-2-oxopyrrolidine-3-carboxamide
“A104”
N-(3-Chloro-5-fluorobenzyl)-(R)-3-hydroxy-2-oxo-1-[3-
(piperidin-1-carbonyl)phenyl]pyrrolidine-3-carboxamide
“A105”
N-(3-Chloro-5-fluorobenzyl)-(R)-3-hydroxy-2-oxo-1-(1-oxo-
1,2,3,4-tetrahydroisoquinolin-6-yl)pyrrolidine-3-carboxamide
“A106”
N-(3-Chloro-5-fluorobenzyl)-(R)-1-(6-cyanopyridin-3-yl)-
3-hydroxy-2-oxopyrrolidine-3-carboxamide
“A107”
N-(3-Chloro-5-fluorobenzyl)-(S)-1-(5-cyanopyridin-3-yl)-
3-hydroxy-2-oxopyrrolidine-3-carboxamide
“A108”
N-(3-Chloro-5-fluorobenzyl)-(R)-3-hydroxy-2-oxo-1-(6-
trifluoromethylpyridin-3-yl)pyrrolidine-3-carboxamide
“A109”
N-(3-Chloro-5-fluorobenzyl)-(R)-3-hydroxy-4,4-dimethyl-
2-oxo-1-phenylpyrrolidine-3-carboxamide
“A110”
(S)-3-(2-Benzylacryloyl)-3-hydroxy-1-phenylpyrrolidin-2-one
“A111”
(R)-3-(2-Benzylacryloyl)-3-hydroxy-1-phenylpyrrolidin-2-one
“A112”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-1-(1-hydroxymethyl-3-
trifluoromethyl-1H-indol-5-yl)-2-oxopyrrolidine-3-carboxamide
“A113”
N-(3-Chloro-5-fluorobenzyl)-8-hydroxy-7-oxo-6-phenyl-2-oxa-
6-azaspiro[3.4]octane-8-carboxamide
“A114”
N-(3-Chloro-5-fluorobenzyl)-1-(8-fluoro-2-oxo-1,2,3,4-
tetrahydroquinolin-6-yl)-3-hydroxy-2-oxopyrrolidine-3-
carboxamide
“A115”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-2-oxo-1-
(1-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)pyrrolidine-
3-carboxamide
“A116”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-1-(6-methylamino-
pyridin-3-yl)-2-oxopyrrolidine-3-carboxamide
“A117”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-1-(5-
methylpyridin-3-yl)-2-oxopyrrolidine-3-carboxamide
“A118”
N-(3-Chloro-5-fluorobenzyl)-1-(3,4-Dihydro-
2H-pyrido[3,2-b]-1,4-oxazin-7-yl)-
3-hydroxy-2-oxopyrrolidine-3-carboxamide
“A119”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-5-methyl-2-
oxo-1-phenylpyrrolidine-3-carboxamide
“A120”
3-[(3-Chloro-5-fluorobenzylamino)methyl]-1-
phenylpyrrolidin-3-ol
“A121”
N-(3-Chloro-5-fluorobenzyl)-1-benzyl-3-
hydroxypyrrolidine-3-carboxamide
“A122”
N-(3-Chloro-5-fluorobenzyl)-1-(4-acetylaminocyclohexyl)-
3-hydroxy-2-oxopyrrolidine-3-carboxamide
“A123”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-1-(4-methane-
sulfonylaminocyclohexyl)-2-oxopyrrolidine-3-carboxamide
“A124”
N-(3-Chloro-5-fluorobenzyl)-1-(4-ethanesulfonylamino-
cyclohexyl)-3-hydroxy-2-oxopyrrolidine-3-carboxamide
“A125”
N-(3-Chloro-5-fluorobenzyl)-1-((1S,2R,3S)-2,3-dihydroxy-
cyclohexyl)-3-hydroxy-2-oxopyrrolidine-3-carboxamide
“A126”
N-(3-Chloro-5-fluorobenzyl)-1-(3-acetylaminocyclohexyl)-3-
hydroxy-2-oxopyrrolidine-3-carboxamide
“A127”
N-(3-Chloro-5-fluorobenzyl)-1-(4-ethylaminocyclohexyl)-3-
hydroxy-2-oxopyrrolidine-3-carboxamide
“A128”
N-(3-Chloro-5-fluorobenzyl)-1-(3-ethanesulfonylamino-
cyclohexyl)-3-hydroxy-2-oxopyrrolidine-3-carboxamide
“A129”
N-(3-Chloro-5-fluorobenzyl)-1-((3aR,4S,7aS)-2,2-dimethyl-
hexahydrobenzo-1,3-dioxol-4-yl)-3-hydroxy-2-
oxopyrrolidine-3-carboxamide
“A130”
5-[3-(3-Chloro-5-fluorobenzylcarbamoyl)-3-hydroxy-
2-oxo-pyrrolidin-1-yl]-isophthalamide
“A131”
N-(3-Chloro-5-fluorobenzyl)-(R)-3-hydroxy-2-oxo-
[1,3′]bipyrrolidinyl-3-carboxamide
“A132”
N-(3-Chloro-5-fluorobenzyl)-(R)-3-hydroxy-2-oxo-1-
(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)
pyrrolidine-3-carboxamide
“A133”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-1-(3-
methylcarbamoyl-phenyl)-2-oxopyrrolidine-3-carboxamide
“A134”
N-(3-Chloro-5-fluorobenzyl)-1-(3-
Dimethylcarbamoylphenyl)-3-hydroxy-2-
oxopyrrolidine-3-carboxamide
“A135”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-1-
(4-methoxybenzyl)-2-oxopyrrolidine-3-carboxamide
“A136”
N-(3-Chloro-5-fluorobenzyl)-1-benzyl-3-hydroxy-
2-oxo-pyrrolidine-3-carboxamide
“A137”
N-[2-(3-Chloro-5-fluorophenyl)ethyl]-3-hydroxy-
2-oxo-1-(2-oxo-1,2,3,4-tetrahydroquinolin-
6-yl)pyrrolidine-3-carboxamide
“A138”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-1-(6-
methoxypyridin-3-yl)-2-oxopyrrolidine-3-carboxamide
“A139”
N-[2-(3-Chloro-5-fluorophenyl)ethyl]-1-(6-
acetylaminopyridin-3-yl)-3-hydroxy-2-
oxopyrrolidine-3-carboxamide
“A140”
N-(3-Chloro-5-fluorobenzyl)-(S)-1-benzyl-3-hydroxy-
2-oxo-pyrrolidine-3-carboxamide
“A141”
N-(3-Chloro-5-fluorobenzyl)-(R)-1-benzyl-3-hydroxy-
2-oxo-pyrrolidine-3-carboxamide
“A142”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-1-[5-methyl-
6-(3-oxo-morpholin-4-yl)-pyridin-3-yl]-2-
oxopyrrolidine-3-carboxamide
“A143”
N-[2-(2-Trifluoromethylphenyl)ethyl]-1-(6-
acetylaminopyridin-3-yl)-3-hydroxy-2-
oxopyrrolidine-3-carboxamide
“A144”
N-[2-(2-Trifluoromethylphenyl)ethyl]-1-
(3-carbamoylphenyl)-3-hydroxy-2-
oxopyrrolidine-3-carboxamide
“A145”
N-[1-(3-Fluorophenyl)ethyl]-3-hydroxy-2-oxo-1-
phenyl-pyrrolidine-3-carboxamide
“A146”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-1-
(2-methylcarbamoyl-benzofuran-5-yl)-2-
oxopyrrolidine-3-carboxamide
“A147”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-2-oxo-1-(2-oxo-
1,2-dihydroquinolin-6-yl)pyrrolidine-3-carboxamide
“A148”
Ethyl 4-[3-(3-chloro-5-fluorobenzylcarbamoyl)-3-hydroxy-
2-oxopyrrolidin-1-yl]-cyclohexanecarboxylate
“A149”
N-[2-(3-Chloro-5-fluorophenyl)ethyl]-(S)-3-hydroxy-
2-oxo-1-(2-oxo-1,2,3,4-tetrahydroquinolin-
6-yl)pyrrolidine-3-carboxamide
“A150”
N-[2-(3-Chloro-5-fluorophenyl)ethyl]-(R)-3-
hydroxy-2-oxo-1-(2-oxo-1,2,3,4-tetrahydroquinolin-
6-yl)pyrrolidine-3-carboxamide
“A151”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-2-oxo-1-
(3-oxo-3,4-dihydro-2H-benzo-1,4-oxazin-
7-yl)pyrrolidine-3-carboxamide
“A152”
4-[3-(3-Chloro-5-fluorobenzylcarbamoyl)-3-hydroxy-
2-oxo-pyrrolidin-1-yl]-cyclohexanecarboxylic acid
“A153”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-1-
(1H-indol-6-yl)-2-oxopyrrolidine-3-carboxamide
“A154”
N-(3-Chloro-5-fluorobenzyl)-(R)-3-hydroxy-1-
(1H-indol-6-yl)-2-oxopyrrolidine-3-carboxamide
“A155”
N-[2-(3-Chloro-5-fluorophenyl)ethyl]-(S)-1-(6-acetylamino-
pyridin-3-yl)-3-hydroxy-2-oxopyrrolidine-3-carboxamide
“A156”
N-[2-(3-Chloro-5-fluorophenyl)ethyl]-(R)-1-(6-acetylamino-
pyridin-3-yl)-3-hydroxy-2-oxopyrrolidine-3-carboxamide
“A157”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-1-(4-methylcarbamoyl-
cyclohexyl)-2-oxopyrrolidine-3-carboxamide
“A158”
N-(2-Oxo-1,2,3,4-tetrahydroquinolin-6-yl)-2-oxo-1-(2-oxo-
1,2,3,4-tetrahydroquinolin-6-yl)pyrrolidine-3-carboxamide
“A159”
N-[2-(3-Chloro-5-fluorophenyl)ethyl]-(R)-1-(3-carbamoyl-
phenyl)-3-hydroxy-2-oxopyrrolidine-3-carboxamide
“A160”
N-(3-Chloro-5-fluorobenzyl)-(R)-3-hydroxy-1-(3-methane-
sulfonylaminophenyl)-2-oxopyrrolidine-3-carboxamide
“A161”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-1-(3-methyl-
carbamoylphenyl)-2-oxopyrrolidine-3-carboxamide
“A162”
N-(3-Chloro-5-fluorobenzyl)-(R)-3-hydroxy-1-(3-methyl-
carbamoylphenyl)-2-oxopyrrolidine-3-carboxamide
“A163”
N-(3-Chloro-5-fluorobenzyl)-(S)-1-(3-cyclobutylcarbamoyl-
phenyl)-3-hydroxy-2-oxopyrrolidine-3-carboxamide
“A164”
N-(3-Chloro-5-fluorobenzyl)-(R)-1-(3-cyclobutylcarbamoyl-
phenyl)-3-hydroxy-2-oxopyrrolidine-3-carboxamide
“A165”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-1-[3-(methane-
sulfonylmethylamino)phenyl]-2-oxopyrrolidine-3-carboxamide
“A166”
N-(3-Chloro-5-fluorobenzyl)-(R)-3-hydroxy-1-[3-(methane-
sulfonylmethylamino)phenyl]-2-oxopyrrolidine-3-carboxamide
“A167”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-2-oxo-1-[6-(3-oxo-
morpholin-4-yl)-pyridin-3-yl]pyrrolidine-3-carboxamide
“A168”
N-([2-(3-Chloro-5-fluorophenyl)ethyl]-3-hydoxy-1-(1H-
indazol-5-yl)-2-oxopyrrolidine-3-carboxamide
“A169”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-2-oxo-1-(1-phenyl-
1H-pyrazol-4-yl)pyrrolidine-3-carboxamide
“A170”
tert-Butyl 4-{4-[3-(3-chloro-5-fluorobenzylcarbamoyl)-3-
hydroxy-2-oxopyrrolidin-1-yl]-pyrazol-1-yl}-piperidine-1-
carboxylate
“A171”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-2-oxo-1-(6-
propionylaminopyridin-3-yl)pyrrolidine-3-carboxamide
“A172”
N-(3-Chloro-5-fluorobenzyl)-(R)-3-hydroxy-2-oxo-1-(6-
propionylaminopyridin-3-yl)pyrrolidine-3-carboxamide
“A173”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-1-(6-morpholin-4-
yl-pyridin-3-yl)-2-oxopyrrolidine-3-carboxamide
“A174”
N-[2-(3-Fluorophenyl)ethyl]-1-(6-acetylaminopyridin-3-yl)-
3-hydroxy-2-oxopyrrolidine-3-carboxamide
“A175”
N-[2-(2-Fluorophenyl)ethyl]-1-(6-acetylaminopyridin-3-yl)-
3-hydroxy-2-oxopyrrolidine-3-carboxamide
“A176”
N-(3,5-Difluorobenzyl)-1-(6-acetylaminopyridin-3-yl)-
3-hydroxy-2-oxopyrrolidine-3-carboxamide
“A177”
N-[2-(3-Fluorophenyl)ethyl]-1-(3-carbamoylphenyl)-3-
hydroxy-2-oxopyrrolidine-3-carboxamide
“A178”
N-(3,5-Difluorobenzyl)-1-(3-carbamoylphenyl)-3-
hydroxy-2-oxopyrrolidine-3-carboxamide
“A179”
N-[2-(2-Fluorophenyl)ethyl]-1-(3-carbamoylphenyl)-3-
hydroxy-2-oxopyrrolidine-3-carboxamide
“A180”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-2-oxo-1-(1-piperidin-
4-yl-1H-pyrazol-4-yl)pyrrolidine-3-carboxamide
“A181”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-1-(4-methoxy-
benzyl)-2-oxopyrrolidine-3-carboxamide
“A182”
N-(3-Chloro-5-fluorobenzyl)-(R)-3-hydroxy-1-(4-methoxy-
benzyl)-2-oxopyrrolidine-3-carboxamide
“A183”
N-[2-(3-Fluorophenyl)ethyl]-3-hydroxy-2-oxo-1-(2-oxo-
1,2,3,4-tetrahydroquinolin-6-yl)pyrrolidine-3-carboxamide
“A184”
N-[2-(2-Fluorophenyl)ethyl]-3-hydroxy-2-oxo-1-(2-oxo-
1,2,3,4-tetrahydroquinolin-6-yl)pyrrolidine-3-carboxamide
“A185”
N-(3,5-Difluorobenzyl)-3-hydroxy-2-oxo-1-(2-oxo-1,2,3,4-
tetrahydroquinolin-6-yl)pyrrolidine-3-carboxamide
"A186”
N-(2-Chloro-3-fluorobenzyl)-1-(6-acetylaminopyridin-3-yl)-
3-hydroxy-2-oxopyrrolidine-3-carboxamide
“A187”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-2-oxo-1-phenyl-
carbamoylmethylpyrrolidine-3-carboxamide
“A188”
N-[2-(3,5-Difluorophenyl)ethyl]-1-(6-acetylaminopyridin-
3-yl)-3-hydroxy-2-oxopyrrolidine-3-carboxamide
“A189”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-1-(1H-indazol-
5-yl)-2-oxopyrrolidine-3-carboxamide
“A190”
N-(3-Chloro-5-fluorobenzyl)-(R)-3-hydroxy-1-(1H-indazol-
5-yl)-2-oxopyrrolidine-3-carboxamide
“A191”
N-[2-(3-Chloro-5-fluorophenyl)ethyl]-(S)-3-hydroxy-1-(1H-
indazol-5-yl)-2-oxopyrrolidine-3-carboxamide
“A192”
N-[2-(3-Chloro-5-fluorophenyl)ethyl]-(R)-3-hydroxy-1-(1H-
indazol-5-yl)-2-oxopyrrolidine-3-carboxamide
“A193”
N-(2-Chloro-3-fluorobenzyl)-1-(3-carbamoylphenyl)-3-
hydroxy-2-oxopyrrolidine-3-carboxamide
“A194”
N-(3-Chloro-5-fluorobenzyl)-(S)-1-(2-ethylcarbamoyl-
benzofuran-5-yl)-3-hydroxy-2-oxopyrrolidine-3-carboxamide
“A195”
N-(3-Chloro-5-fluorobenzyl)-(R)-1-(2-ethylcarbamoyl-
benzofuran-5-yl)-3-hydroxy-2-oxopyrrolidine-3-carboxamide
“A196”
N-(2-Chloro-3-fluorobenzyl)-3-hydroxy-2-oxo-1-
(2-oxo-1,2,3,4-tetrahydroquinolin-
6-yl)pyrrolidine-3-carboxamide
“A197”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-2-oxo-1-
(3-oxo-3,4-dihydro-2H-benzo-1,4-oxazin-
7-yl)pyrrolidine-3-carboxamide
“A198”
N-(3-Chloro-5-fluorobenzyl)-(R)-3-hydroxy-2-oxo-1-
(3-oxo-3,4-dihydro-2H-benzo-1,4-oxazin-
7-yl)pyrrolidine-3-carboxamide
“A199”
N-[2-(3,5-Difluorophenyl)ethyl]-3-hydroxy-2-oxo-1-
(2-oxo-1,2,3,4-tetrahydroquinolin-6-
yl)pyrrolidine-3-carboxamide
"A200”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-1-(2-methyl-1H-
indol-5-yl)-2-oxopyrrolidine-3-carboxamide
“A201”
N-[2-(3,5-Difluorophenyl)ethyl]-1-(3-carbamoylphenyl)-3-
hydroxy-2-oxopyrrolidine-3-carboxamide
“A202”
Ethyl 3-[3-(3-chloro-5-fluorobenzylcarbamoyl)-3-hydroxy-2-
oxopyrrolidin-1-yl]-cyclohexanecarboxylate
“A203”
[3-(3-Chloro-5-fluorobenzylcarbamoyl)-3-hydroxy-2-oxo-
pyrrolidin-1-yl]-acetic acid
“A204”
N-(3-Chloro-5-fluorobenzyl)-1-(3-carbamoyl-5-
trifluoromethyl-phenyl)-3-hydroxy-2-
oxopyrrolidine-3-carboxamide
“A205”
Ethyl 5-[3-(3-chloro-5-fluorobenzylcarbamoyl)-3-
hydroxy-2-oxopyrrolidin-1-yl]-1H-indol-2-carboxylate
“A206”
N-(2-Chloro-3-fluorobenzyl)-3-hydroxy-1-(1H-
indol-5-yl)-2-oxopyrrolidine-3-carboxamide
“A207”
N-[2-(3,5-Difluorophenyl)ethyl]-3-hydroxy-1-(1H-
indol-5-yl)-2-oxopyrrolidine-3-carboxamide
“A208”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-1-methylcarbamoyl-
methyl-2-oxopyrrolidine-3-carboxamide
“A209”
N-(3,5-Difluorobenzyl)-3-hydroxy-1-(1H-indol-5-yl)-
2-oxo-pyrrolidine-3-carboxamide
“A210”
N-[2-(2-Fluorophenyl)ethyl]-3-hydroxy-1-(1H-indol-5-yl)-
2-oxo-pyrrolidine-3-carboxamide
“A211”
5-[3-(3-Chloro-5-fluorobenzylcarbamoyl)-3-hydroxy-2-oxo-
pyrrolidin-1-yl]-1H-indole-2-carboxamide
“A212”
N-[2-(3-Fluorophenyl)ethyl]-3-hydroxy-1-(1H-indol-5-yl)-
2-oxo-pyrrolidine-3-carboxamide
“A213”
tert-Butyl 3-[3-(3-chloro-5-fluorobenzylcarbamoyl)-3-
hydroxy-2-oxopyrrolidin-1-ylmethyl]-azetidine-1-carboxylate
“A214”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-2-oxo-1-
(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-
3-yl)pyrrolidine-3-carboxamide
“A215”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-2-oxo-1-(1H-
pyrrolo[2,3-b]pyridin-5-yl)pyrrolidine-3-carboxamide
“A216”
5-[3-(3-Chloro-5-fluorobenzylcarbamoyl)-3-hydroxy-2-oxo-
pyrrolidin-1-yl]-nicotinamide
“A217”
N-(3-Chloro-5-fluorobenzyl)-1-(2-cyano-1H-indol-5-yl)-3-
hydroxy-2-oxopyrrolidine-3-carboxamide
“A218”
N-(3-Chloro-5-fluorobenzyl)-1-azetidin-3-ylmethyl-3-
hydroxy-2-oxopyrrolidine-3-carboxamide
“A219”
N-(3-Chloro-5-fluorobenzyl)-1-[2-(5-fluoro-1H-indol-3-yl)-
ethyl]-3-hydroxy-2-oxopyrrolidine-3-carboxamide
“A220”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-2-oxo-1-(tetrahydro-
pyran-4-ylmethyl)pyrrolidine-3-carboxamide
“A221”
N-[2-(3,5-Difluorophenyl)ethyl]-(S)-3-hydroxy-2-oxo-1-(2-
oxo-1,2,3,4-tetrahydroquinolin-6-yl)pyrrolidine-3-carboxamide
“A222”
N-(3-Chloro-5-fluorobenzyl)-(S)-1-(3-cyano-1H-indol-5-yl)-
3-hydroxy-2-oxopyrrolidine-3-carboxamide
“A223”
N-[2-(3,5-Difluorophenyl)ethyl]-(R)-3-hydroxy-
2-oxo-1-(2-oxo-1,2,3,4-tetrahydroquinolin-
6-yl)pyrrolidine-3-carboxamide
“A224”
N-(3-Chloro-5-fluorobenzyl)-(R)-1-(3-cyano-1H-indol-
5-yl)-3-hydroxy-2-oxopyrrolidine-3-carboxamide
“A225”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-2-oxo-1-[(R)-1-
(tetrahydrofuran-2-yl)methyl]pyrrolidine-3-carboxamide
“A226”
4-[3-(3-Chloro-5-fluorobenzylcarbamoyl)-3-hydroxy-2-oxo-
pyrrolidin-1-ylmethyl]cyclohexanecarboxylic acid
“A227”
4-[3-(3-Chloro-5-fluorobenzylcarbamoyl)-3-hydroxy-2-oxo-
pyrrolidin-1-ylmethyl]cyclohexanecarboxylic acid
“A228”
tert-Butyl (1S,5R,65)-6-[3-(3-chloro-5-
fluorobenzylcarbamoyl)-3-hydroxy-2-oxopyrrolidin-1-yl]-
3-azabicyclo[3.1.0]hexane-3-carboxylate
“A229”
N-(3-Chloro-5-fluorobenzyl)-1-(1S,5R,65)-3-azabicyclo-
[3.1.0]hex-6-yl-3-hydroxy-2-oxopyrrolidine-3-carboxamide
“A230”
N-(3-Chloro-5-fluorobenzyl)-1-((1S,5R,65)-3-
ethanesulfonyl-3-azabicyclo[3.1.0]hex-6-yl)-3-hydroxy-2-
oxopyrrolidine-3-carboxamide
“A231”
N-(3-Chloro-5-fluorobenzyl)-1-((1S,5R,65)-
3-acetyl-3-aza-bicyclo[3.1.0]hex-6-yl)-3-hydroxy-2-
oxopyrrolidine-3-carboxamide
“A232”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-1-(1-methyl-1H-
benzimidazol-2-ylmethyl)-2-oxopyrrolidine-3-carboxamide
“A233”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-2-oxo-
[1,3′]bipyrrolidinyl-3-carboxamide
“A234”
N-(2-Chloro-4,5-difluorobenzyl)-(S)-3-hydroxy-
2-oxo-1-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)
pyrrolidine-3-carboxamide
“A235”
N-(5-Chloro-2,4-difluorobenzyl)-(S)-3-hydroxy-
2-oxo-1-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)
pyrrolidine-3-carboxamide
“A236”
N-(2,4,6-Trifluorobenzyl)-(S)-3-hydroxy-
2-oxo-1-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)
pyrrolidine-3-carboxamide
“A237”
N-(3-Chloro-5-fluorobenzyl)-1-[2-(2,4-Difluorophenyl)
ethyl]-3-hydroxy-2-oxopyrrolidine-3-carboxamide
“A238”
5-[(S)-3-(3-Chloro-5-fluorobenzylcarbamoyl)-3-
hydroxy-2-oxo-pyrrolidin-1-yl]-1H-indole-3-carboxamide
“A239”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-1-
(2-methyl-1H-indol-5-yl)-2-oxopyrrolidine-3-carboxamide
“A240”
N-(3-Chloro-5-fluorobenzyl)-(R)-3-hydroxy-1-
(2-methyl-1H-indol-5-yl)-2-oxopyrrolidine-3-carboxamide
“A241”
N-(4-Chloro-2-fluorobenzyl)-(S)-3-hydroxy-2-oxo-1-(2-oxo-
1,2,3,4-tetrahydroquinolin-6-yl)pyrrolidine-3-carboxamide
“A242”
N-(2-Chloro-4-fluorobenzyl)-(S)-3-hydroxy-2-oxo-1-(2-oxo-
1,2,3,4-tetrahydroquinolin-6-yl)pyrrolidine-3-carboxamide
“A243”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-2-oxo-1-[(S)-1-
(tetrahydrofuran-2-yl)methyl]pyrrolidine-3-carboxamide
“A244”
N-(2-Chloro-3,6-difluorobenzyl)-(S)-3-hydroxy-
2-oxo-1-(2-oxo-1,2,3,4-tetrahydroquinolin-
6-yl)pyrrolidine-3-carboxamide
“A245”
N-(2,4,5-Trifluorobenzyl)-(S)-3-hydroxy-
2-oxo-1-(2-oxo-1,2,3,4-tetrahydroquinolin-
6-yl)pyrrolidine-3-carboxamide
“A246”
N-(2,3,6-Trifluorobenzyl)-(S)-3-hydroxy-2-oxo-1-
(2-oxo-1,2,3,4-tetrahydroquinolin-
6-yl)pyrrolidine-3-carboxamide
“A247”
N-(3-Chloro-4-fluorobenzyl)-(S)-3-hydroxy-
2-oxo-1-(2-oxo-1,2,3,4-tetrahydroquinolin-
6-yl)pyrrolidine-3-carboxamide
“A248”
N-(3-Chloro-5-fluorobenzyl)-1-carbamoylmethyl-
3-hydroxy-2-oxopyrrolidine-3-carboxamide
“A249”
N-(4-Chloro-2,6-difluorobenzyl)-(S)-3-hydroxy-
2-oxo-1-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)
pyrrolidine-3-carboxamide
“A250”
N-(3-Chloro-2,6-difluorobenzyl)-(S)-3-hydroxy-
2-oxo-1-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)
pyrrolidine-3-carboxamide
“A251”
N-(3-Chloro-2,4-difluorobenzyl)-(S)-3-hydroxy-
2-oxo-1-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)
pyrrolidine-3-carboxamide
“A252”
N-(3,5-Difluorobenzyl)-1-cyclobutylmethyl-3-
hydroxy-2-oxo-piperidine-3-carboxamide
“A253”
N-(3-Fluorobenzyl)-1-(3,4-difluorobenzyl)-3-
hydroxy-2-oxo-piperidine-3-carboxamide
“A254”
N-(3-Fluorobenzyl)-(S)-1-(2,3-difluorobenzyl)-3-
hydroxy-2-oxo-piperidine-3-carboxamide
“A255”
N-(4-Fluorobenzyl)-(S)-1-(2,3-difluorobenzyl)-3-
hydroxy-2-oxo-piperidine-3-carboxamide
“A256”
N-(3-Fluorobenzyl)-(S)-1-cyclohexylmethyl-3-
hydroxy-2-oxo-piperidine-3-carboxamide
“A257”
N-(4-Fluorobenzyl)-1-(3,4-difluorobenzyl)-3-
hydroxy-2-oxo-piperidine-3-carboxamide
“A258”
N-(5-Methylisoxazol-3-ylmethyl)-1-(3,4-difluorobenzyl)-
3-hydroxy-2-oxopiperidine-3-carboxamide
“A259”
N-(Pyridin-2-ylmethyl)-(S)-1-(2,3-difluorobenzyl)-3-
hydroxy-2-oxopiperidine-3-carboxamide
“A260”
N-(Pyridin-2-ylmethyl)-(R)-1-(2,3-difluorobenzyl)-3-
hydroxy-2-oxopiperidine-3-carboxamide
“A261”
N-(3-Fluorobenzyl)-(R)-1-(2,3-difluorobenzyl)-3-
hydroxy-2-oxo-piperidine-3-carboxamide
“A262”
N-(4-Fluorobenzyl)-(R)-1-(2,3-difluorobenzyl)-3-
hydroxy-2-oxo-piperidine-3-carboxamide
“A263”
N-(3-Fluorobenzyl)-(R)-1-cyclohexylmethyl-3-
hydroxy-2-oxo-piperidine-3-carboxamide
“A264”
N-(3,4,5-Trifluorobenzyl)-(S)-3-hydroxy-2-oxo-1-(2-oxo-
1,2,3,4-tetrahydroquinolin-6-yl)pyrrolidine-3-carboxamide
“A265”
N-(4-Chloro-3-fluorobenzyl)-(S)-3-hydroxy-2-oxo-1-(2-oxo-
1,2,3,4-tetrahydroquinolin-6-yl)pyrrolidine-3-carboxamide
“A266”
N-(2,3,5-Trifluorobenzyl)-(S)-3-hydroxy-2-oxo-1-(2-oxo-
1,2,3,4-tetrahydroquinolin-6-yl)pyrrolidine-3-carboxamide
“A267”
3-(1,3-Dihydroisoindole-2-carbonyl)-3-hydroxy-1-phenyl-
pyrrolidin-2-one
“A268”
1-Benzyl-3-(1,3-dihydroisoindole-2-carbonyl)-3-hydroxy-
pyrrolidin-2-one
“A269”
N-(3-Chloro-5-fluorobenzyl)-1-(1H-benzimidazol-2-
ylmethyl)-3-hydroxy-2-oxopyrrolidine-3-carboxamide
“A270”
N-(3-Chloro-5-fluorobenzyl)-1-benzothiazol-2-ylmethyl-3-
hydroxy-2-oxopyrrolidine-3-carboxamide
“A271”
3-[3-(3-Chloro-5-fluorobenzylcarbamoyl)-3-hydroxy-2-oxo-
pyrrolidin-1-yl]-propionic acid
“A272”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-1-(3-methyl-3H-
imidazol-4-ylmethyl)-2-oxopyrrolidine-3-carboxamide
“A273”
4-[3-(3-Chloro-5-fluorobenzylcarbamoyl)-3-hydroxy-2-oxo-
pyrrolidin-1-ylmethyl]cyclohexanecarboxylic acid
“A274”
4-[3-(3-Chloro-5-fluorobenzylcarbamoyl)-3-hydroxy-2-oxo-
pyrrolidin-1-ylmethyl]cyclohexanecarboxylic acid
“A275”
N-(3-Chloro-5-fluorobenzyl)-1-((1S,5R,6S)-3-ethyl-3-aza-
bicyclo[3.1.0]hex-6-yl)-3-hydroxy-2-oxopyrrolidine-3-
carboxamide
“A276”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-1-(2-methyl-
2H-pyrazol-3-ylmethyl)-2-oxopyrrolidine-3-carboxamide
“A277”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-2-oxo-1-(1H-
pyrazol-3-ylmethyl)pyrrolidine-3-carboxamide
“A278”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-1-
(4-methylcarbamoyl-cyclohexylmethyl)-2-
oxopyrrolidine-3-carboxamide
“A279”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-1-(1H-imidazol-
4-ylmethyl)-2-oxopyrrolidine-3-carboxamide
“A280”
N-(3-Chloro-5-fluorobenzyl)-1-(1,5-Dimethyl-1H-pyrrol-
2-ylmethyl)-3-hydroxy-2-oxopyrrolidine-3-carboxamide
“A281”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-1′-
methanesulfonyl-2-oxo[1,3′]bipyrrolidinyl-3-carboxamide
“A282”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-1-[(2-hydroxy-
ethylcarbamoyl)methyl]-2-oxopyrrolidine-3-carboxamide
“A283”
N-(2-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-2-oxo-1-(2-oxo-
1,2,3,4-tetrahydroquinolin-6-yl)pyrrolidine-3-carboxamide
“A284”
N-(2,3,4-Trifluorobenzyl)-(S)-3-hydroxy-2-oxo-1-(2-oxo-
1,2,3,4-tetrahydroquinolin-6-yl)pyrrolidine-3-carboxamide
“A285”
N-(2,3-Difluorobenzyl)-(S)-3-hydroxy-2-oxo-1-(2-oxo-
1,2,3,4-tetrahydroquinolin-6-yl)pyrrolidine-3-carboxamide
“A286”
N-(3-Chloro-5-fluorobenzyl)-(S)-1-(3,3-difluoro-
2-oxo-2,3-dihydro-1H-indol-5-yl)-3-hydroxy-2-
oxopyrrolidine-3-carboxamide
“A287”
N-(3-Fluorobenzyl)-1-(4-fluorobenzyl)-3-hydroxy-
2-oxo-piperidine-3-carboxamide
“A288”
N-(3-Chloro-5-fluorobenzyl)-(R)-1-(3,3-difluoro-
2-oxo-2,3-dihydro-1H-indol-5-yl)-3-hydroxy-2-
oxopyrrolidine-3-carboxamide
“A289”
N-(2,6-Difluorobenzyl)-(S)-3-hydroxy-2-oxo-1-
(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)
pyrrolidine-3-carboxamide
“A290”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-1-(5-methyl-1,3,4-
oxadiazol-2-ylmethyl)-2-oxopyrrolidine-3-carboxamide
“A291”
N-(3-chloro-5-fluorobenzyl-)(R)-1′-acetyl-3-hydroxy-2-oxo-
[1,3′]bipyrrolidinyl-3-carboxamide
“A292”
N-(3-Chloro-5-fluorobenzyl)-(R)-3-hydroxy-1′-
methanesulfonyl-2-oxo[1,3′]bipyrrolidinyl-3-carboxamide
“A293”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-1-
(4-methylcyclohexyl)-2-oxopyrrolidine-3-carboxamide
“A294”
N-(5-Methylisoxazol-3-ylmethyl)-1-(2,3-Difluorobenzyl)-
3-hydroxy-2-oxopiperidine-3-carboxamide
“A295”
N-(4-Methylbenzyl)-1-(2,3-difluorobenzyl)-3-hydroxy-
2-oxo-piperidine-3-carboxamide
"A296”
N-(2-Fluorobenzyl)-1-(2,3-difluorobenzyl)-3-hydroxy-
2-oxo-piperidine-3-carboxamide
“A297”
N-(5-Methylpyrazin-2-ylmethyl)-1-(2,3-difluorobenzyl)-
3-hydroxy-2-oxopiperidine-3-carboxamide
“A298”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-2-oxo-1-
pyridin-2-ylpyrrolidine-3-carboxamide
“A299”
N-(3-Chloro-5-fluorobenzyl)-(R)-3-hydroxy-2-oxo-1-
pyridin-2-ylpyrrolidine-3-carboxamide
“A300”
N-(3-Chloro-5-fluorobenzyl)-1-(2-carbamoylethyl)-3-
hydroxy-2-oxopyrrolidine-3-carboxamide
“A301”
N-(3-Chloro-5-fluorobenzyl)-1-benzyl-3-
hydroxypiperidine-3-carboxamide
“A302”
3-[(3-Chloro-5-fluorobenzylamino)methyl]-3-
hydroxy-1-phenyl-piperidin-2-one
“A303”
N-(3-Chloro-5-fluorobenzyl)-3,4-dihydroxy-
2-oxo-1-(2-oxo-1,2,3,4-tetrahydroquinolin-
6-yl)pyrrolidine-3-carboxamide
“A304”
N-(3-Chloro-5-fluorobenzyl)-5-fluoro-3-hydroxy-
2-oxo-1-(2-oxo-1,2,3,4-tetrahydroquinolin-
6-yl)pyrrolidine-3-carboxamide
“B1”
N-(3-Chloro-5-fluorobenzyl)-(S)-1-(2-cyano-1H-indol-
5-yl)-3-hydroxy-2-oxopyrrolidine-3-carboxamide
“B2”
N-(3-Chloro-5-fluorobenzyl)-(S)-1-(8-fluoro-
2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)-3-hydroxy-2-
oxopyrrolidine-3-carboxamide
“B3”
N-(2-Chloro-6-fluorobenzyl)-
(S)-3-hydroxy-2-oxo-1-(2-oxo-1,2,3,4-tetrahydroquinolin-
6-yl)-pyrrolidine-3-carboxamide
“B4”
N-(5-Chloro-2-fluorobenzyl)-(S)-3-hydroxy-2-oxo-1-(2-oxo-
1,2,3,4-tetrahydroquinolin-6-yl)pyrrolidine-3-carboxamide
“B5”
N-[2-(2-Fluorophenyl)ethyl]-(S)-3-hydroxy-2-oxo-1-(2-oxo-
1,2,3,4-tetrahydroquinolin-6-yl)pyrrolidine-3-carboxamide
“B6”
N-[2-(3-Fluorophenyl)ethyl]-(S)-3-hydroxy-2-oxo-1-(2-oxo-
1,2,3,4-tetrahydroquinolin-6-yl)pyrrolidine-3-carboxamide
“B7”
N-(3,5-Difluorobenzyl)-(S)-3-hydroxy-2-oxo-1-(2-oxo-
1,2,3,4-tetrahydroquinolin-6-yl)pyrrolidine-3-carboxamide
“B8”
N-(3,5-Difluorobenzyl)-(S)-3-hydroxy-1-(1H-indol-5-yl)-
2-oxo-pyrrolidine-3-carboxamide
“B9”
N-(2-Chloro-3-fluorobenzyl)-(S)-1-(6-acetylaminopyridin-
3-yl)-3-hydroxy-2-oxopyrrolidine-3-carboxamide
“B10”
N-([2-(3-Fluorophenyl)ethyl]-(S)-3-hydroxy-1-(1H-indol-
5-yl)-2-oxopyrrolidine-3-carboxamide
“B11”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-2-oxo-1-(1H-
pyrrolo[2,3-b]pyridin-5-yl)pyrrolidine-3-carboxamide
“B12”
N-(3-Chloro-5-fluorobenzyl)-1-(4-chloro-2-methoxy-5-
methyl-phenyl)-3-hydroxy-2-oxopyrrolidine-3-carboxamide
“B13”
1-(5-Chloro-2-methoxyphenyl)-3-hydroxy-2-oxopyrrolidine-
3-carboxylic acid 3-chloro-5-fluorobenzylamide
“B14”
(S)-3-hydroxy-1-(1H-indol-5-yl)-2-oxopyrrolidine-3-
carboxylic acid [2-(2-fluorophenyl)ethyl]-amide
“B15”
N-(2-Chloro-3-fluorobenzyl)-(S)-3-hydroxy-
2-oxo-1-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)
pyrrolidine-3-carboxamide
“B16”
N-(3-Chloro-5-fluorobenzyl)-1-benzyl-3-
hydroxypiperidine-3-carboxamide
"B17”
N-(3-Chloro-5-fluorobenzyl)-(S)-1-(4-bromo-3-
hydroxymethyl-phenyl)-3-hydroxy-2-oxopyrrolidine-
3-carboxamide
“B18”
3-[(3-Chloro-5-fluorobenzylamino)methyl]-1-
cyclohexylmethyl-3-hydroxypiperidin-2-one
“B19”
1-Benzyl-3-[(3-chloro-5-fluorobenzylamino)methyl]-
piperidin-3-ol
“B20”
1-Benzyl-3-[(3-fluorobenzylamino)methyl]-piperidin-3-ol
“B21”
(S)-1-Benzyl-3-[(4-fluorobenzylamino)methyl]-piperidin-3-ol
“B22”
(S)-1-(2,3-Difluorobenzyl)-3-[(3-fluorobenzylamino)methyl]-
3-hydroxypiperidin-2-one
“B23”
(R)-1-(2,3-Difluorobenzyl)-3-[(3-fluorobenzylamino)methyl]-
3-hydroxypiperidin-2-one
“B24”
N-(2,5-Difluorobenzyl)-(S)-3-hydroxy-2-oxo-1-(2-oxo-1,2,3,4-
tetrahydroquinolin-6-yl)pyrrolidine-3-carboxamide
“B25”
N-(3-Chloro-2-fluorobenzyl)-(S)-3-hydroxy-2-oxo-1-(2-oxo-
1,2,3,4-tetrahydroquinolin-6-yl)pyrrolidine-3-carboxamide
“B26”
N-(3-Chloro-5-fluorobenzyl)-1-(2-Fluoro-5-trifluoromethyl-
phenyl)-3-hydroxy-2-oxopyrrolidine-3-carboxamide
“B27”
N-(3-Chloro-5-fluorobenzyl)-1-(4-Chloro-3-trifluoromethyl-
phenyl)-3-hydroxy-2-oxopyrrolidine-3-carboxamide
“B28”
N-(3-Chloro-5-fluorobenzyl)-1-(3-carbamoyl-4-fluorophenyl)-
3-hydroxy-2-oxopyrrolidine-3-carboxamide
“B29”
3-[(3-Chloro-5-fluorobenzylamino)methyl]-3-hydroxy-1-
phenyl-pyrrolidin-2-one
“B30”
1-Benzyl-3-[(3-chloro-5-fluorobenzylamino)methyl]
pyrrolidin-3-ol
“B31”
1-Benzyl-3-[(3-chloro-5-fluorobenzylamino)methyl]-
3-hydroxy-piperidin-2-one
“B32”
3-[(3-Chloro-5-fluorobenzylamino)methyl]-3-
hydroxy-1-phenyl-piperidin-2-one
“B33”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-1-(2-methyl-3H-
imidazo[4,5-b]pyridin-6-yl)-2-oxopyrrolidine-3-carboxamide
“B34”
N-(3-Chloro-2,5-difluorobenzyl)-(S)-3-hydroxy-
2-oxo-1-(2-oxo-1,2,3,4-tetrahydroquinolin-
6-yl)pyrrolidine-3-carboxamide
“B35”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-1-(3H-imidazo
[4,5-b]-pyridin-6-yl)-2-oxopyrrolidine-3-carboxamide
“B36”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-2-oxo-
1-(2-trifluoromethyl-3H-imidazo[4,5-b]pyridin-6-yl)
pyrrolidine-3-carboxamide
“B37”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-1-[2-(1H-
indol-3-yl)ethyl]-2-oxopyrrolidine-3-carboxamide
“B38”
N-(3-Chloro-5-fluorobenzyl)-(R)-3-hydroxy-1-[2-(1H-
indol-3-yl)ethyl]-2-oxopyrrolidine-3-carboxamide
“B39”
N-(3-Chloro-5-fluorobenzyl)-(S)-1-(2-Fluoro-5-
trifluoromethyl-phenyl)-3-
hydroxy-2-oxopyrrolidine-3-carboxamide
“B40”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-2-oxo-1-
(2-oxo-1,2-dihydroquinolin-
6-yl)pyrrolidine-3-carboxamide
“B41”
N-(3-Chloro-5-fluorobenzyl)-(R)-3-hydroxy-2-oxo-1-
(2-oxo-1,2-dihydroquinolin-
6-yl)pyrrolidine-3-carboxamide
“B42”
N-(3-Chloro-5-fluorobenzyl)-(R)-1-(2-Fluoro-
5-trifluoromethyl-phenyl)-3-hydroxy-
2-oxopyrrolidine-3-carboxamide
“B43”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-2-oxo-1-
(3-trifluoromethyl-1H-indol-5-
yl)pyrrolidine-3-carboxamide
“B44”
1-Benzyl-3-[(3,5-difluorobenzylamino)methyl]-
piperidin-3-ol
“B45”
3-[(4-Fluorobenzylamino)methyl]-3-hydroxy-1-
phenylpyrrolidin-2-one
“B46”
3-[(3,5-Difluorobenzylamino)methyl]-3-hydroxy-
1-phenyl-pyrrolidin-2-one
“B47”
3-{[2-(4-Fluorophenyl)ethylamino]methyl}-3-
hydroxy-1-phenyl-pyrrolidin-2-one
“B48”
3-[(3-Fluorobenzylamino)methyl]-3-hydroxy-1-
phenylpyrrolidin-2-one
“B49”
3-Hydroxy-3-[(4-methylbenzylamino)methyl]-1-
phenyl-pyrrolidin-2-one
“B50”
N-(2-Oxo-1,2,3,4-tetrahydroquinolin-6-yl)-3-
hydroxy-2-oxo-1-(2-oxo-1,2,3,4-tetrahydroquinolin-
6-yl)pyrrolidine-3-carboxamide
"B51”
3-Benzyl 1-tert-butyl 3-hydroxy-2-oxopyrrolidine-
1,3-dicarboxylate
“B52”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-2-oxo-1-(4-
trifluoromethylpyridin-2-yl)pyrrolidine-3-carboxamide
“B53”
1-Benzyl 3-isopropyl 3-hydroxy-2-oxopyrrolidine-1,3-
dicarboxylate
“B54”
(S)-1-Benzyl-3-[(3-chloro-5-fluorobenzylamino)methyl]-3-
hydroxypiperidin-2-one
“B55”
(R)-1-Benzyl-3-[(3-chloro-5-fluorobenzylamino)methyl]-3-
hydroxypiperidin-2-one
“B56”
N-(3-Fluorobenzyl)-(S)-3-hydroxy-2-oxo-1-(2-oxo-1,2,3,4-
tetrahydroquinolin-6-yl)pyrrolidine-3-carboxamide
“B57”
N-(3-Fluorobenzyl)-(R)-3-hydroxy-2-oxo-1-(2-oxo-1,2,3,4-
tetrahydroquinolin-6-yl)pyrrolidine-3-carboxamide
“B58”
(R)-3-[(3-Chloro-5-fluorobenzylamino)methyl]-3-hydroxy-1-
phenylpyrrolidin-2-one
“B59”
(S)-3-[(3-Chloro-5-fluorobenzylamino)methyl]-3-hydroxy-1-
phenylpyrrolidin-2-one
“B60”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-1-(1H-indazol-3-
ylmethyl)-2-oxopyrrolidine-3-carboxamide
“B61”
N-(3-Chloro-5-fluorobenzyl)-(R)-3-hydroxy-1-(2-methyl-1H-
pyrrolo[2,3-b]pyridin-5-yl)-2-oxopyrrolidine-3-carboxamide
“B62”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-1-(2-methyl-1H-
pyrrolo[2,3-b]pyridin-5-yl)-2-oxopyrrolidine-3-carboxamide
“B63”
(S)-3-[(3-Chloro-5-fluorobenzylamino)methyl]-1-
cyclohexylmethyl-3-hydroxypiperidin-2-one
"B64”
(R)-3-[(3-Chloro-5-fluorobenzylamino)methyl]-1-
cyclohexylmethyl-3-hydroxypiperidin-2-one
“B65”
N-(3-Chloro-5-fluorobenzyl)-(S)-1-(2-fluoro-4-trifluoromethyl-
phenyl)-3-hydroxy-2-oxopyrrolidine-3-carboxamide
“B66”
N-(3-Chloro-5-fluorobenzyl)-(S)-1-(2-fluoro-4-methylphenyl)-
3-hydroxy-2-oxopyrrolidine-3-carboxamide
“B67”
N-(3-Chloro-5-fluorobenzyl)-1-(2-fluoro-5-trifluoromethyl-
phenyl)-3-hydroxy-2-oxopiperidine-3-carboxamide
“B68”
6-{3-[(3-Chloro-5-fluorobenzylamino)methyl]-3-hydroxy-2-
oxo-piperidin-1-yl}-3,4-dihydro-1H-quinolin-2-one
“B69”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-2-oxo-1-(2-oxo-
1,2,3,4-tetrahydroquinolin-6-ylmethyl)pyrrolidine-3-
carboxamide
“B70”
N-(3-Chloro-5-fluorobenzyl)-(S)-1-(5-carbamoyl-2-fluoro-
phenyl)-3-hydroxy-2-oxopyrrolidine-3-carboxamide
“B71”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-2-oxo-1-
(2-oxo-2,3-dihydro-1H-benzimidazol-
5-yl)pyrrolidine-3-carboxamide
“B72”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-2-oxo-1-(2-
trifluoromethyl-1H-indol-5-yl)pyrrolidine-3-carboxamide
“B73”
N-(3-Chloro-5-fluorobenzyl)-(R)-3-hydroxy-2-oxo-1-(3-
trifluoromethyl-1H-indol-5-yl)pyrrolidine-3-carboxamide
“B74”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-2-oxo-1-
(3-trifluoro-methyl-1H-indol-
5-yl)pyrrolidine-3-carboxamide
“B75”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-2-oxo-1-(1H-
pyrazolo[3,4-b]pyridin-5-yl)pyrrolidine-3-carboxamide
“B76”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-2-oxo-1-
(2-trifluoro-methyl-1H-pyrrolo[2,3-b]pyridin-
5-yl)pyrrolidine-3-carboxamide
“B77”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-2-oxo-1-
(2-oxo-2,3-dihydrobenzothiazol-6-yl)
pyrrolidine-3-carboxamide
“B78”
5-[(S)-3-(3-Chloro-5-fluorobenzylcarbamoyl)-3-hydroxy-
2-oxo-pyrrolidin-1-yl]-1H-indole-2-carboxamide
“B79”
5-[(R)-3-(3-Chloro-5-fluorobenzylcarbamoyl)-3-hydroxy-
2-oxo-pyrrolidin-1-yl]-1H-indole-2-carboxamide
“B80”
Ethyl 5-[(S)-3-(3-chloro-5-fluorobenzylcarbamoyl)-3-
hydroxy-2-oxopyrrolidin-1-yl]-1H-indole-2-carboxylate
“B81”
Ethyl 5-[(R)-3-(3-chloro-5-fluorobenzylcarbamoyl)-3-
hydroxy-2-oxopyrrolidin-1-yl]-1H-indole-2-carboxylate
“B82”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-1-(2-methoxyethyl)-
1H-pyrazol-4-yl]-2-oxopyrrolidine-3-carboxamide
“B83”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-2-oxo-1-
(2-trifluoromethyl-1H-pyrrolo[2,3-b]pyridin-5-yl)
pyrrolidine-3-carboxamide
“B84”
5-[(S)-3-(3-Chloro-5-fluorobenzylcarbamoyl)-3-hydroxy--
2-oxopyrrolidin-1-yl]-1H-indole-2-carboxylic acid
“B85”
5-[(R)-3-(3-Chloro-5-fluorobenzylcarbamoyl)-3-hydroxy-
2-oxo-pyrrolidin-1-yl]-1H-indole-2-carboxylic acid
“B86”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-2-oxo-1-(2-
trifluoromethyl-1H-indol-5-yl)pyrrolidine-3-carboxamide
“B87”
N-(3-Chloro-5-fluorobenzyl)-1-(1-cyanomethyl-1H-pyrazol-
4-yl)-3-hydroxy-2-oxopyrrolidine-3-carboxamide
“B88”
N-Ethyl-5-[(R)-3-(3-chloro-5-fluorobenzylcarbamoyl)-3-
hydroxy-2-oxopyrrolidin-1-yl]-1H-indole-2-carboxamide
“B89”
N-Isopropyl-5-[(R)-3-(3-chloro-5-fluorobenzylcarbamoyl)-
3-hydroxy-2-oxopyrrolidin-1-yl]-1H-indole-2-carboxamide
“B90”
N,N-Dimethyl-5-[(R)-3-(3-chloro-5-fluorobenzylcarbamoyl)-
3-hydroxy-2-oxopyrrolidin-1-yl]-1H-indole-2-carboxamide
“B91”
3-(3-Chloro-5-fluorobenzylcarbamoyl)-2-oxo-1-(2-oxo-
1,2,3,4-tetrahydroquinolin-6-yl)pyrrolidin-3-yl acetate
“B92”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-1-(3H-imidazo-
[4,5-b]pyridin-6-yl)-2-oxopyrrolidine-3-carboxamide
“B93”
N-(3-Chloro-5-fluorobenzyl)-(R)-3-hydroxy-1-(3H-imidazo-
[4,5-b]pyridin-6-yl)-2-oxopyrrolidine-3-carboxamide
“B94”
N-Ethyl-5-[(S)-3-(3-chloro-5-fluorobenzylcarbamoyl)-3-
hydroxy-2-oxopyrrolidin-1-yl]-1H-indole-2-carboxamide
“B95”
N,N-Dimethyl-5-[(S)-3-(3-chloro-5-fluorobenzylcarbamoyl)-
3-hydroxy-2-oxopyrrolidin-1-yl]-1H-indole-2-carboxamide
“B96”
N-Methyl-5-[(S)-3-(3-chloro-5-fluorobenzylcarbamoyl)-3-
hydroxy-2-oxopyrrolidin-1-yl]-1H-indole-2-carboxamide
“B97”
N-Isopropyl-5-[(S)-3-(3-chloro-5-fluorobenzylcarbamoyl)-
3-hydroxy-2-oxopyrrolidin-1-yl]-1H-indole-2-carboxamide
“B98”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-2-oxo-1-(2-oxo-
1,2,3,4-tetrahydroquinolin-6-yl)pyrrolidine-3-carboxamide
“B99”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-1-[1-(2-methoxy-
ethyl)-1H-pyrazol-4-yl]-2-oxopyrrolidine-3-carboxamide
“B100”
N-(3-Chloro-5-fluorobenzyl)-(R)-3-hydroxy-1-[1-(2-methoxy-
ethyl)-1H-pyrazol-4-yl]-2-oxopyrrolidine-3-carboxamide
“B101”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-2-oxo-1-(4-
sulfamoylphenyl)pyrrolidine-3-carboxamide
“B102”
N-Methyl-5-[(R)-3-(3-chloro-5-fluorobenzylcarbamoyl)-3-
hydroxy-2-oxopyrrolidin-1-yl]-1H-indole-2-carboxamide
“B103”
(S)-3-Hydroxy-2-oxo-1-(2-oxo-1,2,3,4-tetrahydroquinolin-
6-yl)-pyrrolidine-3-carboxamide
“B104”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-2-oxo-1-
(3-trifluoro-methyl-1H-pyrrolo[2,3-b]pyridin-
5-yl)pyrrolidine-3-carboxamide
“B105”
Methyl 3-{2-tert-butoxycarbonylamino-5-[3-(3-chloro-5-
fluorobenzylcarbamoyl)-3-hydroxy-2-oxopyrrolidin-1-yl]-
phenyl}propionate
“B106”
3-{2-tert-Butoxycarbonylamino-5-[3-(3-chloro-5-
fluorobenzyl-carbamoyl)-3-hydroxy-2-oxopyrrolidin-1-yl]
phenyl}propionic acid
“B107”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-2-oxo-1-
(3-sulfamoyl-phenyl)pyrrolidine-3-carboxamide
“B108”
N-({2-[2-(2-Aminoethoxy)-ethoxy]ethyl})-5-[(S)-3-
(3-chloro-5-fluorobenzylcarbamoyl)-3-hydroxy-2-
oxopyrrolidin-1-yl]-1H-indole-2-carboxamide
“B109”
N-(3-Chloro-5-fluorobenzyl)-1-(7-fluoro-2-oxo-1,2,3,4-
tetrahydroquinolin-6-yl)-3-hydroxy-2-oxopyrrolidine-3-
carboxamide
“B110”
N-[2-(3,5-Difluorophenyl)ethyl]-(S)-3-hydroxy-1-
(1H-indol-5-yl)-2-oxopyrrolidine-3-carboxamide
“B111”
N-[2-(3,5-Difluorophenyl)ethyl]-(R)-3-hydroxy-1- (1H-indol-5-yl)-2-oxopyrrolidine-3-carboxamide
“B112”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-1-[2-
(morpholine-4-carbonyl)-1H-indol-
5-yl]-2-oxopyrrolidine-3-carboxamide
“B113”
N-[2-(2-Aminoethoxy)ethyl]-5-[(S)-3-(3-chloro-5-
fluorobenzylcarbamoyl)-3-hydroxy-2-oxopyrrolidin-1-yl]-
1H-indole-2-carboxamide
“B114”
N-(3-Chloro-5-fluorobenzyl)-(S)-1-[2-(azetidine-1-
carbonyl)-1H-indol-5-yl]-3-hydroxy-2-
oxopyrrolidine-3-carboxamide
“B115”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-2-oxo-1-
(4-sulfamoyl-phenyl)pyrrolidine-3-carboxamide
“B116”
N-(3-Chloro-5-fluorobenzyl)-(S)-1-(1-cyanomethyl-1H-
pyrazol-4-yl)-3-hydroxy-2-oxopyrrolidine-3-carboxamide
“B117”
N-(3-Chloro-5-fluorobenzyl)-(R)-1-(1-cyanomethyl-1H-
pyrazol-4-yl)-3-hydroxy-2-oxopyrrolidine-3-carboxamide
“B118”
N-(3-Chloro-5-fluorobenzyl)-1-(4-acetylsulfamoylphenyl)-
3-hydroxy-2-oxopyrrolidine-3-carboxamide
“B119”
N-(3-Chloro-5-fluorobenzyl)-(S)-1-(1-carbamoylmethyl-1H-
pyrazol-4-yl)-3-hydroxy-2-oxopyrrolidine-3-carboxamide
“B120”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-2-oxo-1-(1-phenyl-
ethyl)pyrrolidine-3-carboxamide
“B121”
N-(2-hydroxyethyl)-5-[(S)-3-(3-chloro-5-fluorobenzyl-
carbamoyl)-3-hydroxy-2-oxopyrrolidin-1-yl]-1H-indole-2-
carboxamide
“B122”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-1-[2-(4-methyl-
piperazin-1-carbonyl)-1H-indol-5-yl]-2-oxopyrrolidine-3-
carboxamide
“B123”
tert-Butyl 4-{5-[(S)-3-(3-chloro-5-fluorobenzylcarbamoyl)-
3-hydroxy-2-oxopyrrolidin-1-yl]-1H-indol-2-carbonyl}-
piperazine-1-carboxylate
“B124”
N-(3-Chloro-5-fluorobenzyl)-1-(5-fluoro-2-oxo-1,2,3,4-
tetrahydroquinolin-6-yl)-3-hydroxy-2-oxopyrrolidine-3-
carboxamide
“B125”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-2-oxo-1-(2-oxo-
2,3-dihydro-1H-indol-5-yl)pyrrolidine-3-carboxamide
“B126”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-2-oxo-1-
[2-(piperazin-1-carbonyl)-1H-indol-
5-yl]pyrrolidine-3-carboxamide
“B127”
N-(3-Chloro-5-fluorobenzyl)-3-chloro-2-oxo-1-(2-oxo-
1,2,3,4-tetrahydroquinolin-6-yl)pyrrolidine-3-carboxamide
“B128”
N-(3-Chloro-5-fluorobenzyl)-(S)-1-(3-dimethylsulfamoyl-
phenyl)-3-hydroxy-2-oxopyrrolidine-3-carboxamide
“B129”
N-(2-Aminophenyl)-5-[(S)-3-(3-chloro-5-fluorobenzyl-
carbamoyl)-3-hydroxy-2-oxopyrrolidin-1-yl]-1H-indole-
2-carboxamide
“B130”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-2-oxo-
1-(2-oxo-2,3-dihydro-1H-indol-5-yl)pyrrolidine-
3-carboxamide
“B131”
N-(3-Chloro-5-fluorobenzyl)-(R)-3-hydroxy-2-oxo-1-
(2-oxo-2,3-dihydro-1H-indol-5-yl)pyrrolidine-
3-carboxamide
“B132”
N-(2-Aminoethyl)-5-[(S)-3-(3-chloro-5-
fluorobenzylcarbamoyl)-3-hydroxy-2-
oxopyrrolidin-1-yl]-1H-indole-2-carboxamide
“B133”
N-(3-Chloro-5-fluorobenzyl)-(S)-1-[2-(1H-
benzoimidazol-2-yl)-1H-indol-5-yl]-
3-hydroxy-2-oxopyrrolidine-3-carboxamide
“B134”
N-(3-Chloro-5-fluorobenzyl)-(S)-1-(2-hydrazinocarbonyl-
1H-indol-5-yl)-3-hydroxy-2-oxopyrrolidine-3-carboxamide
“B135”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-1-[2-(3-methyl-
1,2,4-oxadiazol-5-yl)-1H-indol-5-yl]-2-oxopyrrolidine-3-
carboxamide
“B136”
N-(3-Chloro-5-fluorobenzyl)-(S)-1-benzyloxy-3-
hydroxy-2-oxo-pyrrolidine-3-carboxamide
“B137”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-2-
oxopyrrolidine-3-carboxamide
“B138”
N-(3-Chloro-5-fluorobenzyl)-(R)-1-benzyloxy-3-
hydroxy-2-oxo-pyrrolidine-3-carboxamide
“B139”
N-(3-Chloro-5-fluorobenzyl)-(8)-3-hydroxy-
2-oxo-1-(3-trifluoro-methyl-1H-pyrrolo[2,3-b]
pyridin-5-yl)pyrrolidine-3-carboxamide
“B140”
N-(3-Chloro-5-fluorobenzyl)-(R)-3-hydroxy-2-oxo-1-
(3-trifluoromethyl-1H-pyrrolo[2,3-b]pyridin-
5-yl)pyrrolidine-3-carboxamide
“B141”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-1-(4-methyl-
sulfamoylphenyl)-2-oxopyrrolidine-3-carboxamide
“B142”
N-(3-Chloro-5-fluorobenzyl)-(S)-1-(4-
benzylsulfamoylphenyl)-3-hydroxy-2-
oxopyrrolidine-3-carboxamide
“B143”
N-(3-Chloro-5-fluorobenzyl)-(S)-1-[4-
(benzylmethylsulfamoyl)-phenyl]-3-hydroxy-2-
oxopyrrolidine-3-carboxamide
“B144”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-1-(1-methyl-
1H-indol-5-yl)-2-oxopyrrolidine-3-carboxamide
“B145”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-1-
hydroxymethyl-2-oxopyrrolidine-3-carboxamide
“B146”
N-(3-Chloro-5-fluorobenzyl)-(R)-3-hydroxy-1-
hydroxymethyl-2-oxopyrrolidine-3-carboxamide
“B147”
N-(3-Chloro-5-fluorobenzyl)-(S)-1-(3-chloro-1H-pyrrolo
[2,3-b]-pyridin-5-yl)-3-hydroxy-2-
oxopyrrolidine-3-carboxamide
“B148”
N-(3-Chloro-5-fluorobenzyl)-3-hydroxy-2-oxo-1-(2-
trifluoromethyl-1H-benzimidazol-5-yl)pyrrolidine-3-
carboxamide
“B149”
N-(3-Chloro-5-fluorobenzyl)-(S)-3-hydroxy-2-oxo-1-(2-
sulfamoyl-1H-indol-5-yl)pyrrolidine-3-carboxamide
“B150”
(3S)-N-[(3-Chloro-5-fluorophenyl)methyl]-1-(2,2-dioxo-
1,3-dihydro-2,1-benzothiazol-5-yl)-3-hydroxy-
2-oxopyrrolidine-3-carboxamide
“B151”
N-(3-Chloro-5-fluorobenzyl)-(S)-1-(2,2-dioxo-
1,2,3,4-tetrahydro-2lamda*6*-benzo[c]thiazin-
6-yl)-3-hydroxy-2-oxo-1-
(2-sulfamoyl-1H-indol-5-yl)pyrrolidine-3-carboxamide
“B152”
N-(3-Chloro-5-fluorobenzyl)-(S)-1-[((R)-1-
dimethylcarbamoyl-2-methylpropylcarbamoyl)methyl]-
3-hydroxy-2-oxo-1-(2-sulfamoyl-1H-indol-5-yl)
pyrrolidine-3-carboxamide
“B153”
N-(3-Chloro-5-fluorobenzyl)-(S)-1-R(S)-3-amino-1-
methylcarbamoylpropylcarbamoyl)methyl]-3-
hydroxy-2-oxo-1-(2-sulfamoyl-1H-indol-5-yl)
pyrrolidine-3-carboxamide
“B154”
N-(3-Hydroxy-2-oxo-1-phenylpyrrolidin-3-yl)benzamide
and pharmaceutically usable salts, tautomers and stereoisomers thereof, including mixtures thereof in all ratios.

### Claim 6 (depends on 1)

Process for the preparation of compounds of the formula I according to claim 1 and pharmaceutically usable salts, tautomers and stereoisomers thereof, characterised in that
a) for the preparation of compounds of the formula I in which
Y denotes CO and R denotes NR2R4,
a compound of the formula II
in which X, R, R3, R5, R6, R7 and p have the meanings indicated in claim 1, and L denotes Cl, Br, I or a free or reactively functionally modified OH group,
is reacted with a compound of the formula III
R2—NHR4 III
in which R2 and R4 have the meanings indicated in claim 1,
or
b) a compound of the formula IV
in which R, R5, R6, R7, R, X, Y and p have the meanings indicated in claim 1,
is oxidised,
or
c) for the preparation of compounds of the formula I in which
X and Y denote CH2,
a compound of the formula I in which X and Y denote CO,
is reduced,
and/or
a base or acid of the formula I is converted into one of its salts.

### Claim 7 (depends on 1)

Medicaments comprising at least one compound of the formula I according to claim 1 and/or pharmaceutically usable salts, tautomers and stereoisomers thereof, including mixtures thereof in all ratios, and optionally excipients and/or adjuvants.

### Claim 8 (depends on 1)

A method for the treatment of tumours, tumour metastases, proliferative diseases of the mesangial cells, haemangioma, proliferative retinopathy, rheumatoid arthritis, atherosclerotic neovascularisation, psoriasis, ocular neovascularisation, osteoporosis, diabetes and obesity, lymphoid leukaemia, lymphoma, malaria or prostate hypertrophy, which comprises administering a compounds of the formula I according to claim 1, and pharmaceutically usable salts, tautomers and stereoisomers thereof, including mixtures thereof in all ratios.

### Claim 9 (depends on 8)

A method according to claim 8, where the tumour disease is selected from the group of the squamous epithelium, of the bladder, of the stomach, of the kidneys, of head and neck, of the oesophagus, of the cervix, of the thyroid, of the intestine, of the liver, of the brain, of the prostate, of the urogenital tract, of the lymphatic system, of the stomach, of the larynx, of the lung, of the skin, monocytic leukaemia, lung adenocarcinoma, small-cell lung carcinoma, pancreatic cancer, glioblastoma, breast carcinoma, acute myeloid leukaemia, chronic myeloid leukaemia, acute lymphatic leukaemia, chronic lymphatic leukaemia, Hodgkin's lymphoma, non-Hodgkin's lymphoma,

### Claim 10 (depends on 8)

Method according to claim 8 for the treatment of tumours, where a therapeutically effective amount of a compound of the formula I is administered in combination with a compound from the group 1) oestrogen receptor modulator, 2) androgen receptor modulator, 3) retinoid receptor modulator, 4) cytotoxic agent, 5) antiproliferative agent, 6) prenyl-protein transferase inhibitor, 7) HMG-CoA reductase inhibitor, 8) HIV protease inhibitor, 9) reverse transcriptase inhibitor and 10) further angiogenesis inhibitors.

### Claim 11 (depends on 8)

Method according to claim 8 for the treatment of tumours where a therapeutically effective amount of a compound of the formula I is administered in combination with radiotherapy and a compound from the group 1) oestrogen receptor modulator, 2) androgen receptor modulator, 3) retinoid receptor modulator, 4) cytotoxic agent, 5) antiproliferative agent, 6) prenyl-protein transferase inhibitor, 7) HMG-CoA reductase inhibitor, 8) HIV protease inhibitor, 9) reverse transcriptase inhibitor and 10) further angiogenesis inhibitors.
